These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17043343)

  • 21. Polish Forum for Prevention Guidelines on Prophylactic Pharmacotherapy: update 2017.
    Podolec P; Filipiak KJ; Undas A; Pająk A; Godycki-Ćwirko M; Drygas W; Zdrojewski T; Jankowski P; Podolec J; Komar M; Sarnecka A; Kozek E; Czarnecka D; Małecki M; Nowicka G; Członkowska A; Niewada M; Stańczyk J; Windak A; Guzik T; Kopeć G
    Kardiol Pol; 2017; 75(5):508-511. PubMed ID: 28530029
    [No Abstract]   [Full Text] [Related]  

  • 22. Introduction.
    Chilton RJ
    Am J Cardiol; 2017 Jul; 120(1S):S1-S3. PubMed ID: 28606339
    [No Abstract]   [Full Text] [Related]  

  • 23. Depression and anxiety in the practice of cardiology.
    Dudek D; Jaeschke R; Styczeń K; Pilecki M
    Kardiol Pol; 2013; 71(8):781-6. PubMed ID: 24037672
    [No Abstract]   [Full Text] [Related]  

  • 24. [Main causes of death of patients with diabetes mellitus].
    Balen SA; Borovik LN; Cherkasov IA
    Probl Endokrinol (Mosk); 1976; 22(6):14-8. PubMed ID: 1019105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Audit confirms conclusions of UGDP study on oral diabetes drugs.
    FDA Drug Bull; 1978 Dec-1979 Jan; 8(6):34-6. PubMed ID: 720789
    [No Abstract]   [Full Text] [Related]  

  • 26. 2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    ; Drozda JP; Ferguson TB; Jneid H; Krumholz HM; Nallamothu BK; Olin JW; Ting HH; ; Heidenreich PA; Albert NM; Chan PS; Curtis LH; Ferguson TB; Fonarow GC; Ho PM; O'Brien S; Russo AM; Thomas RJ; Ting HH; Varosy PD
    Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):68-95. PubMed ID: 26666514
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary and secondary prevention in diabetic patients: are we not aggressive enough?
    Murrone A; Santucci A; Cavallini C
    J Cardiovasc Med (Hagerstown); 2017 Jan; 18 Suppl 1():e83-e90. PubMed ID: 27922928
    [No Abstract]   [Full Text] [Related]  

  • 28. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology.
    Piepoli MF; Corrà U; Adamopoulos S; Benzer W; Bjarnason-Wehrens B; Cupples M; Dendale P; Doherty P; Gaita D; Höfer S; McGee H; Mendes M; Niebauer J; Pogosova N; Garcia-Porrero E; Rauch B; Schmid JP; Giannuzzi P
    Eur J Prev Cardiol; 2014 Jun; 21(6):664-81. PubMed ID: 22718797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of Cardiology.
    Budoff MJ; Raggi P; Beller GA; Berman DS; Druz RS; Malik S; Rigolin VH; Weigold WG; Soman P;
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):176-92. PubMed ID: 26846937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The heart and diabetes. Problems posed by the use of cardio-vascular drugs and therapeutic errors to be avoided in diabetic cardiac patients].
    Grand A
    Coeur Med Interne; 1978; 17(2):259-70. PubMed ID: 26495
    [No Abstract]   [Full Text] [Related]  

  • 31. Body-mass index and mortality.
    Gaziano TA; Opie LH
    Lancet; 2009 Jul; 374(9684):113-4; author reply 114. PubMed ID: 19595336
    [No Abstract]   [Full Text] [Related]  

  • 32. [The cardiovascular system in surgical diseases in patients with diabetes mellitus].
    SOKOLOVSKII VD
    Probl Endokrinol Gormonoter; 1961; 7():69-78. PubMed ID: 13914893
    [No Abstract]   [Full Text] [Related]  

  • 33. Blood pressure guidelines as starting point in clinical decisions.
    Krumholz HM
    BMJ; 2018 Jan; 360():j5862. PubMed ID: 29295826
    [No Abstract]   [Full Text] [Related]  

  • 34. Erectile dysfunction and cardiovascular disease.
    Russell ST; Khandheria BK; Nehra A
    Mayo Clin Proc; 2004 Jun; 79(6):782-94. PubMed ID: 15182094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
    Schnell O; Erbach M; Hummel M
    Diab Vasc Dis Res; 2012 Oct; 9(4):245-55. PubMed ID: 22508698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathological anatomy of cardiovascular complications in diabetes].
    CROXATTO OC
    Sem Med; 1954 Dec; 105(23):1046-57. PubMed ID: 13238044
    [No Abstract]   [Full Text] [Related]  

  • 38. DIABETES and ischaemic heart disease.
    Br Med J; 1956 Jul; 2(4983):36-7. PubMed ID: 13329378
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperlipidaemia and cardiovascular disease: statin update.
    Roberts AW; Salim M
    Curr Opin Lipidol; 2007 Jun; 18(3):381-3. PubMed ID: 17495613
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical cardiology: physician update: erectile dysfunction and cardiovascular disease.
    Schwartz BG; Kloner RA
    Circulation; 2011 Jan; 123(1):98-101. PubMed ID: 21200016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.